These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Nationwide epidemiologic study for fibrosing interstitial lung disease (F-ILD) in South Korea: a population-based study. Joung KI; Park H; Park S; Shin JY; Kim YH BMC Pulm Med; 2023 Mar; 23(1):98. PubMed ID: 36949407 [TBL] [Abstract][Full Text] [Related]
9. Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Two Italian Referral Centers. Faverio P; Piluso M; De Giacomi F; Della Zoppa M; Cassandro R; Harari S; Luppi F; Pesci A Respiration; 2020; 99(10):838-845. PubMed ID: 33264777 [TBL] [Abstract][Full Text] [Related]
10. Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib. Makino S Mod Rheumatol; 2021 Jan; 31(1):13-19. PubMed ID: 32964766 [TBL] [Abstract][Full Text] [Related]
17. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA. Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950 [TBL] [Abstract][Full Text] [Related]
18. Predictive factors for the long-term use of pirfenidone in patients with fibrosing interstitial lung disease. Katano T; Sekine A; Ikeda S; Yamakawa H; Misumi T; Okabayashi H; Okuda R; Kitamura H; Baba T; Komatsu S; Hagiwara E; Ogura T Respir Investig; 2021 Jul; 59(4):414-420. PubMed ID: 33618993 [TBL] [Abstract][Full Text] [Related]